NCT06069245 is a NA clinical trial of MitoQ in Healthy, sponsored by Ball State University.

Who is sponsoring NCT06069245?

NCT06069245 is sponsored by Ball State University.

What drugs are being tested in NCT06069245?

Interventions in NCT06069245: MitoQ, Placebo.

Is NCT06069245 still recruiting?

NCT06069245 is currently completed. Last updated 5 October 2023.

Last reviewed 2023-10-05 · How we verify

NCT06069245

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MitoQ & Cardiopulmonary Responses During Exercise

Completed NA Last updated 5 October 2023

What this trial tests

NA trial testing MitoQ in Healthy in 9 participants. Completed in 30 April 2023.

Timeline

14 September 2022

Primary endpoint
30 April 2023

30 April 2023

Quick facts

Lead sponsor	Ball State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	9
Start date	14 September 2022
Primary completion	30 April 2023
Estimated completion	30 April 2023
Sites	1 location across United States

Drugs / interventions tested

MitoQ — full drug profile →
Placebo

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Ball State University

Who can join

18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study Purpose: To examine the acute effects of antioxidant supplementation on energy use during a single bout of exercise in apparently healthy adult men and women. Specifically this study examined the acute effect of MitoQ on: 1. cardiopulmonary responses to submax and maximal exercise 2. Energy expenditure and fat/carbohydrate oxidation during sub maximal exercise. In a double-blind, randomized, placebo controlled, cross-over study design, participants performed 2 experimental trials which differed only in the supplement consumed (MitoQ or Placebo). Participants performed identical exercise protocols which consisted of a series of submaximal workloads followed by a ramp protocol to volitional exhaustion.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Roles of reactive oxygen species in inflammation and cancer.
Yu Y, Liu S, Yang L, Song P, et al · · 2024 · cited 62× · PMID 38576456 · DOI 10.1002/mco2.519
Mitochondrial-targeted antioxidant ingestion acutely blunts VO<sub>2max</sub> in physically inactive females.
Hughes RP, Carlini NA, Fleenor BS, Harber MP. · · 2023 · cited 2× · PMID 38061764 · DOI 10.14814/phy2.15871

Verify or expand the search:

Other trials of MitoQ

Trials testing the same drug.

NCT05539625 — Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis · Phase 2 · withdrawn
NCT06424756 — Effects of an Antioxidant Supplement on Blood Vessel Health · Phase 2 · recruiting
NCT06429059 — ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) · Phase 2 · completed
NCT06191965 — MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction · Phase 2, PHASE3 · recruiting
NCT05605548 — Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD) · EARLY_PHASE1 · terminated

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Ball State University trials

Trials by the same sponsor.

NCT07045051 — Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts. · NA · recruiting
NCT06445296 — Postprandial Effects of Animal Versus Plant-Based Protein · NA · recruiting
NCT05872139 — Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging · NA · completed
NCT06085235 — An Investigation Into the Effects of Acute Exercise on Activities of Daily Living and Cognition in Older Adults · NA · completed
NCT05645991 — Coconut Sugar Lowers Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06069245 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ball State University
Last refreshed: 5 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06069245.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing